BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110:1132-1139. [PMID: 30697862 DOI: 10.1111/cas.13954] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Fiorino S, Tateo F, Biase D, Gallo CG, Orlandi PE, Corazza I, Budriesi R, Micucci M, Visani M, Loggi E, Hong W, Pica R, Lari F, Zippi M. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol 2021;16:1105-33. [PMID: 34468163 DOI: 10.2217/fmb-2021-0064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Jia Y, Byers J, Mason H, Qing X. Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type. Acad Pathol 2019;6:2374289519893083. [PMID: 31840047 DOI: 10.1177/2374289519893083] [Reference Citation Analysis]
3 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang H, Fu BB, Gale RP, Liang Y. NK-/T-cell lymphomas. Leukemia 2021;35:2460-8. [PMID: 34117356 DOI: 10.1038/s41375-021-01313-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110:1132-1139. [PMID: 30697862 DOI: 10.1111/cas.13954] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
6 Wang H, Liu J, Zhang Y, Sun L, Zhao M, Luo B. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma. Virus Genes 2021;57:358-68. [PMID: 34146250 DOI: 10.1007/s11262-021-01854-9] [Reference Citation Analysis]
7 Yakushina SA, Kisteneva LB. [Epstein-Barr virus (Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4): replication strategies]. Vopr Virusol 2020;65:191-202. [PMID: 33533222 DOI: 10.36233/0507-4088-2020-65-4-191-202] [Reference Citation Analysis]
8 Peng WX, Liu X, Wang QF, Zhou XY, Luo ZG, Hu XC. Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature. World J Clin Cases 2021; 9(5): 1184-1195 [PMID: 33644183 DOI: 10.12998/wjcc.v9.i5.1184] [Reference Citation Analysis]
9 Cai J, Zhang B, Li Y, Zhu W, Akihisa T, Li W, Kikuchi T, Liu W, Feng F, Zhang J. Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction. Vaccines (Basel) 2021;9:1290. [PMID: 34835222 DOI: 10.3390/vaccines9111290] [Reference Citation Analysis]
10 Filipczak N, Yalamarty SSK, Li X, Parveen F, Torchilin V. Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases. Molecules 2021;26:3304. [PMID: 34072765 DOI: 10.3390/molecules26113304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Xiao Y, He J, Luo S, Dong M, Li W, Liu G, Chen H, Yang X, Huang S. Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma: A Retrospective Study. Front Oncol 2022;12:820302. [DOI: 10.3389/fonc.2022.820302] [Reference Citation Analysis]
12 Kimura H, de Leval L, Cai Q, Kim WS. EBV-associated NK and T-cell lymphoid neoplasms. Curr Opin Oncol 2022. [PMID: 35900729 DOI: 10.1097/CCO.0000000000000889] [Reference Citation Analysis]
13 Zhou P, Liu S, Ji NN, Zhang S, Wang P, Lin B, Yang P, Lin XT, Cai YZ, Wang ZM, Zhou H, Sun SY, Hao XB. Association between variant alleles of major histocompatibility complex class II regulatory genes and nasopharyngeal carcinoma susceptibility. Eur J Cancer Prev 2020;29:531-7. [PMID: 31922974 DOI: 10.1097/CEJ.0000000000000563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T, Kaneda A. Thirty years of Epstein-Barr virus-associated gastric carcinoma. Virchows Arch 2020;476:353-65. [PMID: 31836926 DOI: 10.1007/s00428-019-02724-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Kryst P, Poletajew S, Wyczałkowska-Tomasik A, Gonczar S, Wysocki M, Kapuścińska R, Krajewski W, Zgliczyński W, Pączek L. Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy. J Clin Med 2020;9:E3195. [PMID: 33023077 DOI: 10.3390/jcm9103195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Banko A, Miljanovic D, Lazarevic I, Cirkovic A. A Systematic Review of Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma. Pathogens 2021;10:1057. [PMID: 34451521 DOI: 10.3390/pathogens10081057] [Reference Citation Analysis]
17 Wang Y, Tong Y, Zhang Z, Zheng R, Huang D, Yang J, Zong H, Tan F, Xie Y, Huang H, Zhang X. ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects. Nucleic Acids Res 2021:gkab779. [PMID: 34500462 DOI: 10.1093/nar/gkab779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Marchi E, O'Connor OA. The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management. CA Cancer J Clin 2020;70:47-70. [PMID: 31815293 DOI: 10.3322/caac.21589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
19 He ZC, Yang F, Guo LL, Wei Z, Dong X. LncRNA TP73-AS1 promotes the development of Epstein-Barr virus associated gastric cancer by recruiting PRC2 complex to regulate WIF1 methylation. Cell Signal 2021;:110094. [PMID: 34314802 DOI: 10.1016/j.cellsig.2021.110094] [Reference Citation Analysis]
20 Zhu J, Fang R, Pan Z, Qian X. Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma. BMC Cancer 2022;22:716. [PMID: 35768843 DOI: 10.1186/s12885-022-09438-y] [Reference Citation Analysis]
21 Wołącewicz M, Becht R, Grywalska E, Niedźwiedzka-Rystwej P. Herpesviruses in Head and Neck Cancers. Viruses 2020;12:E172. [PMID: 32028641 DOI: 10.3390/v12020172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Stanjek-cichoracka A, Łaszewska A, Zawadzki F, Kobylska A, Urlik M, Stącel T, Ochman M. Diagnostics of the Epstein-Barr Virus Before and After Lung Transplantation in a Patient With Developing Posttransplant Lymphoproliferative Disease: A Case Report. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.02.028] [Reference Citation Analysis]
23 Schiller JT, Lowy DR. An Introduction to Virus Infections and Human Cancer. Recent Results Cancer Res 2021;217:1-11. [PMID: 33200359 DOI: 10.1007/978-3-030-57362-1_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
24 Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021;10:763. [PMID: 34204243 DOI: 10.3390/pathogens10060763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pereira LMS, França EDS, Costa IB, Lima IT, Freire ABC, Ramos FLDP, Monteiro TAF, Macedo O, Sousa RCM, Freitas FB, Brasil Costa I, Vallinoto ACR. Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection. Viruses 2022;14:168. [DOI: 10.3390/v14020168] [Reference Citation Analysis]
26 Wang H, Zhou L, Yang Y, Luo B. Screening and identification of key genes in EBV-associated gastric carcinoma based on bioinformatics analysis. Pathol Res Pract 2021;222:153439. [PMID: 34020134 DOI: 10.1016/j.prp.2021.153439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Richardo T, Prattapong P, Ngernsombat C, Wisetyaningsih N, Iizasa H, Yoshiyama H, Janvilisri T. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis. Cancers (Basel) 2020;12:E2441. [PMID: 32872147 DOI: 10.3390/cancers12092441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Li J, Zhang Y, Luo B. Effects of Exosomal Viral Components on the Tumor Microenvironment. Cancers 2022;14:3552. [DOI: 10.3390/cancers14143552] [Reference Citation Analysis]
29 Nagelkerke N, Seedat S, Abu-Raddad LJ. Sexual Behavior Surveys Should Ask More: Covering the Diversity of Sexual Behaviors That May Contribute to the Transmission of Pathogens. Sex Transm Dis 2021;48:e119-21. [PMID: 33346590 DOI: 10.1097/OLQ.0000000000001347] [Reference Citation Analysis]
30 Shannon-Lowe C, Rickinson A. The Global Landscape of EBV-Associated Tumors. Front Oncol 2019;9:713. [PMID: 31448229 DOI: 10.3389/fonc.2019.00713] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 33.7] [Reference Citation Analysis]
31 Wang H, Liu W, Luo B. The roles of miRNAs and lncRNAs in Epstein-Barr virus associated epithelial cell tumors. Virus Res 2021;291:198217. [PMID: 33137402 DOI: 10.1016/j.virusres.2020.198217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kitsou K, Iliopoulou M, Spoulou V, Lagiou P, Magiorkinis G. Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review. Front Oncol 2021;11:687631. [PMID: 34778024 DOI: 10.3389/fonc.2021.687631] [Reference Citation Analysis]
33 Mu L, Hu S, Li G, Wu P, Ren C, Lin T, Zhang S, Liang S. Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/2218140] [Reference Citation Analysis]
34 Wu Y, Song T, Chen P, Jiang X, Wang Q, Chen Q. Prolonged siRNA expression in mammalian cells using an Epstein-Barr virus-based plasmid expression system. Biochem Biophys Res Commun 2020;529:51-6. [PMID: 32560818 DOI: 10.1016/j.bbrc.2020.05.219] [Reference Citation Analysis]
35 Tang Y, He X. Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications. Mol Cell Biochem 2021;476:3537-50. [PMID: 33999333 DOI: 10.1007/s11010-021-04176-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Jiang Y, Ding Y, Liu S, Luo B. The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape. Future Virology 2021;16:565-76. [DOI: 10.2217/fvl-2020-0320] [Reference Citation Analysis]
37 Han B, Yang X, Zhang P, Zhang Y, Tu Y, He Z, Li Y, Yuan J, Dong Y, Hosseini DK, Zhou T, Sun H. DNA methylation biomarkers for nasopharyngeal carcinoma. PLoS One 2020;15:e0230524. [PMID: 32271791 DOI: 10.1371/journal.pone.0230524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
38 Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. EBV and the Pathogenesis of NK/T Cell Lymphoma. Cancers (Basel) 2021;13:1414. [PMID: 33808787 DOI: 10.3390/cancers13061414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Yajima M, Kakuta R, Saito Y, Kitaya S, Toyoda A, Ikuta K, Yasuda J, Ohta N, Kanda T. A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing. J Gen Virol 2021;102. [PMID: 33433312 DOI: 10.1099/jgv.0.001549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Soldan SS, Lieberman PM. Epstein-Barr Virus Infection in the Development of Neurological Disorders. Drug Discov Today Dis Models 2020;32:35-52. [PMID: 33897799 DOI: 10.1016/j.ddmod.2020.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]